Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 2
2011 1
2013 2
2014 2
2015 6
2016 2
2017 1
2019 2
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Moving Pharmacogenetics Into Practice: It's All About the Evidence!
Luzum JA, Petry N, Taylor AK, Van Driest SL, Dunnenberger HM, Cavallari LH. Luzum JA, et al. Clin Pharmacol Ther. 2021 Sep;110(3):649-661. doi: 10.1002/cpt.2327. Epub 2021 Jul 7. Clin Pharmacol Ther. 2021. PMID: 34101169 Review.
Therefore, the purpose of this review is to summarize different perspectives on the evidence required for the clinical implementation of pharmacogenetics. ...However, clinicians and practice guidelines from medical societies often rely on RCT da …
Therefore, the purpose of this review is to summarize different perspectives on the evidence required for the clinical impleme …
Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.
Unertl KM, Jaffa H, Field JR, Price L, Peterson JF. Unertl KM, et al. Per Med. 2015;12(4):339-347. doi: 10.2217/pme.15.10. Per Med. 2015. PMID: 26635887 Free PMC article.
AIM: To describe the knowledge and attitudes of clinicians participating in a large pharmacogenomics implementation program. ...CONCLUSIONS: Clinicians identified their own knowledge deficits, workflow integration, and longitudinal responsibility as challenge …
AIM: To describe the knowledge and attitudes of clinicians participating in a large pharmacogenomics implementation program. . …
Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian.
Wu AH, Babic N, Yeo KJ. Wu AH, et al. Per Med. 2009 May;6(3):315-327. doi: 10.2217/pme.09.1. Per Med. 2009. PMID: 29783510
Despite widespread interest in personalized medicine, the implementation of clinical pharmacogenomics has been slow. The major issue for clinicians is the lack of evidence that pharmacogenomic testing improves clinical outcomes and that testing …
Despite widespread interest in personalized medicine, the implementation of clinical pharmacogenomics has been slow. The major …
The Future of Obsessive-Compulsive Spectrum Disorders: A Research Perspective.
Vats T, Fineberg NA, Hollander E. Vats T, et al. Curr Top Behav Neurosci. 2021;49:461-477. doi: 10.1007/7854_2020_208. Curr Top Behav Neurosci. 2021. PMID: 33550566
Research in the field now encompasses diverse disciplines ranging from inflammatory mechanisms to computational psychiatry, to neurocognitive endophenotypes to functional imaging to pharmacogenomics to brain stimulation approaches. As these disorders become more clearly el …
Research in the field now encompasses diverse disciplines ranging from inflammatory mechanisms to computational psychiatry, to neurocognitiv …
Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
Rakesh G, Sumner CR, Alexander JL, Gross LS, Pine J, Slaby A, Garakani A, Baron D. Rakesh G, et al. J Nerv Ment Dis. 2020 Feb;208(2):127-130. doi: 10.1097/NMD.0000000000001107. J Nerv Ment Dis. 2020. PMID: 31895226
Pharmacogenomic testing in clinical psychiatry has grown at an accelerated pace in the last few years and is poised to grow even further. ...Overall, the evidence for pharmacogenomic testing in psychiatry demonstrates strong analytical validity, modest cli
Pharmacogenomic testing in clinical psychiatry has grown at an accelerated pace in the last few years and is poised to grow ev
Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality.
St Sauver JL, Bielinski SJ, Olson JE, Bell EJ, Mc Gree ME, Jacobson DJ, McCormick JB, Caraballo PJ, Takahashi PY, Roger VL, Rohrer Vitek CR. St Sauver JL, et al. Am J Med. 2016 Oct;129(10):1093-1099.e1. doi: 10.1016/j.amjmed.2016.04.009. Epub 2016 May 5. Am J Med. 2016. PMID: 27155109 Free PMC article.
BACKGROUND: Limited information is available regarding primary care clinicians' response to pharmacogenomic clinical decision support (PGx-CDS) alerts integrated in the electronic health record. METHODS: In February 2015, 159 clinicians in the Mayo Cli …
BACKGROUND: Limited information is available regarding primary care clinicians' response to pharmacogenomic clinical de …
Past, present and future perspectives of therapeutic drug monitoring in India.
Advani M, Seetharaman R, Pawar S, Mali S, Lokhande J. Advani M, et al. Int J Clin Pract. 2021 Aug;75(8):e14189. doi: 10.1111/ijcp.14189. Epub 2021 Apr 20. Int J Clin Pract. 2021. PMID: 33774900 Review.
Therapeutic drug monitoring (TDM) is the clinical practice of performing drug assays and interpreting results to maintain constant therapeutic concentrations in patients' bloodstream. ...However, the newer indications such as antimicrobial resistance, tuberculosis a …
Therapeutic drug monitoring (TDM) is the clinical practice of performing drug assays and interpreting results to maintain cons …
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Dias MM, Sorich MJ, Rowland A, Wiese MD, McKinnon RA. Dias MM, et al. Pharm Res. 2017 Aug;34(8):1544-1550. doi: 10.1007/s11095-017-2128-0. Epub 2017 Feb 24. Pharm Res. 2017. PMID: 28236061 Review.
However, despite the potential benefits, pharmacogenetic testing is mostly confined to specialised medical areas, laboratories and centres. Widespread integration into routine clinical practice has been limited by a complex set of issues including regulatory and rei …
However, despite the potential benefits, pharmacogenetic testing is mostly confined to specialised medical areas, laboratories and centres. …
Issues surrounding the health economic evaluation of genomic technologies.
Buchanan J, Wordsworth S, Schuh A. Buchanan J, et al. Pharmacogenomics. 2013 Nov;14(15):1833-47. doi: 10.2217/pgs.13.183. Pharmacogenomics. 2013. PMID: 24236483 Free PMC article. Review.
AIM: Genomic interventions could enable improved disease stratification and individually tailored therapies. However, they have had a limited impact on clinical practice to date due to a lack of evidence, particularly economic evidence. ...Effectiveness data quality …
AIM: Genomic interventions could enable improved disease stratification and individually tailored therapies. However, they have had a limite …
The Value of Genetic and Genomic Technologies: Workshop Summary.
Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health. Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health. Washington (DC): National Academies Press (US); 2010. Washington (DC): National Academies Press (US); 2010. PMID: 21391344 Free Books & Documents. Review.
On March 22, 2010, the roundtable (Institute of Medicine's Roundtable on Translating Genomic-Based Research for Health) convened a public workshop to examine the perceived value of genetic and genomic technologies, both present and future, in clinical practice
On March 22, 2010, the roundtable (Institute of Medicine's Roundtable on Translating Genomic-Based Research for Health) convened a pu …
25 results